Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy flag Italy · Delayed Price · Currency is EUR
1.125
+0.005 (0.45%)
At close: Jul 28, 2026

BIT:ERFO Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.440.320.761.460.37
Cash & Short-Term Investments
0.440.320.761.460.37
Cash Growth
37.17%-58.22%-47.78%295.16%-58.83%
Accounts Receivable
0.590.470.520.40.36
Other Receivables
0.150.130.130.090.19
Total Trade Receivables
0.740.60.640.490.55
Inventory
1.170.990.980.940.65
Other Current Assets
0.310.270.511.020.24
Total Current Assets
2.652.182.93.911.81
Net Property, Plant & Equipment
1.711.872.112.152.07
Other Intangible Assets
2.282.692.562.812.39
Goodwill
00000
Long-Term Investments
3.552.151.860.270.69
Other Long-Term Assets
0.80.920.751.360.18
Total Assets
10.999.8110.1710.57.13
Accounts Payable
0.610.550.480.660.33
Accrued Expenses
0.080.070.050.050.04
Short-Term Debt
0.380.130.130.130.17
Other Current Liabilities
0.510.70.871.071.12
Total Current Liabilities
1.581.451.541.911.66
Long-Term Debt
0.970.240.320.450.58
Other Long-Term Liabilities
0.330.280.230.20.16
Total Long-Term Liabilities
1.310.530.550.640.73
Total Liabilities
2.891.982.092.552.39
Common Stock
1.751.751.751.751.5
Treasury Stock
-0.54-0.56-0.44--
Additional Paid-in Capital
2.752.752.752.75-
Accumulated Other Comprehensive Income
1.961.961.961.961.96
Retained Earnings
2.181.932.061.481.27
Shareholders' Equity
8.17.838.087.944.74
Total Liabilities & Equity
10.999.8110.1710.57.13
Total Debt
1.350.380.450.580.74
Net Cash (Debt)
-0.91-0.060.310.88-0.37
Net Cash Growth
---64.88%--
Net Cash Per Share
-0.11-0.010.030.10-0.25
Book Value
8.17.838.087.944.74
Book Value Per Share
0.950.920.900.883.16
Tangible Book Value
5.825.145.525.132.35
Tangible Book Value Per Share
0.680.610.610.571.56